Gingival overgrowth can be adverse reaction of calcium channel blockers. Although nifedipine is commonly associated with this process, some case reports have also implicated amlodipine as a possible etiology. Here we present a case of a 59-year-old Pakistani female who developed gingival hyperplasia secondary to amlodipine use. We believe that the knowledge about amlodipine-associated gingival hyperplasia is necessary for dentists, so they are able to accurately diagnose this condition and provide appropriate management.
Key words: Gingival hyperplasia, drug induced gingival overgrowth (DIGO), amlodipine.
|
